Melanoma: Staging and Follow-Up

Cancer staging is the process determining to which extent a cancer has spread and where it is located in the body. A thorough staging is of utmost importance, not only because it provides the most accurate prognostic estimation, but also because several crucial decisions, such as the treatment choic...

Full description

Saved in:
Bibliographic Details
Main Authors: Chryssoula Papageorgiou (Author), Zoe Apalla (Author), Sofia-Magdalini Manoli (Author), Konstantinos Lallas (Author), Efstratios Vakirlis (Author), Aimilios Lallas (Author)
Format: Book
Published: Mattioli1885, 2021-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_16a49f013e7d4ebeae8ac1918b14e2c7
042 |a dc 
100 1 0 |a Chryssoula Papageorgiou  |e author 
700 1 0 |a Zoe Apalla  |e author 
700 1 0 |a Sofia-Magdalini Manoli  |e author 
700 1 0 |a Konstantinos Lallas  |e author 
700 1 0 |a Efstratios Vakirlis  |e author 
700 1 0 |a Aimilios Lallas  |e author 
245 0 0 |a Melanoma: Staging and Follow-Up 
260 |b Mattioli1885,   |c 2021-07-01T00:00:00Z. 
500 |a 10.5826/dpc.11S1a162S 
500 |a 2160-9381 
520 |a Cancer staging is the process determining to which extent a cancer has spread and where it is located in the body. A thorough staging is of utmost importance, not only because it provides the most accurate prognostic estimation, but also because several crucial decisions, such as the treatment choice and the follow-up strategy, vary according to the tumor's stage. The current staging system for melanoma is based on the 8th edition of TNM classification issued by the American Joint Committee on Cancer (AJCC) in 2017. It includes a clinical and a pathological staging, both consisting of 5 stages (0-IV). The stage of a melanoma is determined by several factors, among which the Breslow thickness, the pathological presence or absence of ulceration in the primary tumor, the presence and the number of tumor-involved regional lymph nodes, the presence or absence of in-transit, satellite and/or microsatellite metastases, and the presence of distant metastases. Following melanoma diagnosis, an accurate medical workup, in line with the stage and the physical examination, should be performed. A continuous patient monitoring is fundamental to detect a potential relapse or a second primary melanoma and should be lifelong. However, there is still no universally adopted follow-up strategy program and different follow-up schemes have been suggested. Future prospective studies are needed to evaluate different follow-up protocols according to the adopted therapy, as novel recent therapies (targeted and immunotherapies) are being increasingly used. 
546 |a EN 
690 |a Melanoma 
690 |a staging 
690 |a follow-up 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Dermatology Practical & Conceptual, Vol 11, Iss S1 (2021) 
787 0 |n http://dpcj.org/index.php/dpc/article/view/1795 
787 0 |n https://doaj.org/toc/2160-9381 
856 4 1 |u https://doaj.org/article/16a49f013e7d4ebeae8ac1918b14e2c7  |z Connect to this object online.